IceCure Medical (ICCM) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Mar, 2026Company overview and business model
Incorporated in Israel with principal executive offices in Caesarea, Israel and a U.S. representative office in New York.
Operates as an emerging growth company under U.S. securities regulations.
Management team and governance
Chief Executive Officer is Eyal Shamir; Chief Financial Officer is Ronen Tsimerman.
Board includes Ron Mayron (Chairman), Vincent Chun Hung Chan, Yang Huang, Sharon Levita, Li Haixiang, and Yonatan Malca.
U.S. authorized representative is IceCure Medical Inc.
Offering details and pricing
Registration statement filed on Form F-3 for a proposed offering of securities from time to time after effectiveness.
Amendment No. 1 updates the consent of the independent registered public accounting firm.
Partial view of Summaries dataset, powered by Quartr API
Latest events from IceCure Medical
- Medtech firm seeks $100M for growth, facing legal and market risks.ICCM
Registration filing20 Mar 2026 - Record revenue and regulatory milestones drive rapid adoption and improved financial outlook.ICCM
Q4 202517 Mar 2026 - FDA review of ProSense post-market study advances, with stable Q1 revenue and improved cash flexibility.ICCM
Q1 202517 Mar 2026 - First FDA-cleared minimally invasive cryoablation for breast cancer, poised for rapid global growth.ICCM
Company presentation16 Mar 2026 - Sales up 20%, net loss narrows, FDA and Japan reviews expected by early 2025.ICCM
Q2 202423 Jan 2026 - 36% sales growth, margin gains, and FDA panel support set up major 2025 milestones.ICCM
Q3 202412 Jan 2026 - Sales up 8% and North America grew 42%; FDA decision could further accelerate adoption.ICCM
Q4 202426 Dec 2025 - Offering up to $100M in securities, with proceeds for operations and R&D amid geopolitical risks.ICCM
Registration Filing16 Dec 2025 - Raising up to $16.5M via shares and warrants to fund growth, with notable dilution and risk factors.ICCM
Registration Filing29 Nov 2025